We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Thermo Fisher Scientific - Direct Effect Media

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

Sensory Saturator Minimize Needle Injection Pain

By HospiMedica International staff writers
Posted on 20 Jan 2022
Print article
Image: The ShotBlocker eases injection pain (Photo courtesy of Bionix)
Image: The ShotBlocker eases injection pain (Photo courtesy of Bionix)
A simple, non-invasive, and drug free device instantly reduces needle injection pain and anxiety at a fraction of the cost of other methods.

The Bionix (Maumee, OH, USA) ShotBlocker is a washable plastic pad that uses an array of blunt contact points to saturate the sensory signals around an injection site, distracting patients from the pain signals of the needle by utilizing the Gate Theory of Pain. The single-patient pad upholds a sterile environment during injection procedures, and also eliminates costs associated with resterilization, and is available in either 50 or 100 units per box. ShotBlocker is also available in a reusable form.

ShotBlocker blocks the pain of minor injections without using chemical refrigerant sprays, anesthetic creams, or electrical stimulation devices, and can be used for both intramuscular and subcutaneous injections. The device is positioned over the injection site, and the blunt contact points are pressed firmly against the skin. The shot is immediately administered through the central opening. After the injection, ShotBlocker is lifted from the skin and discarded, or given to the patient to retain until the next injection.

“I'm always trying to find solutions for patients to have the best experience in a medical setting. Getting shots can be scary, and sometimes painful, and I wanted to find a way to use science to make that experience better,” said James Huttner, MD, PhD, medical director and vice president of product development for Bionix, who invented the ShotBlocker. “If anxiety or pain is an obstacle for children to receive the COVID-19 vaccine, I think the ShotBlocker can make a real difference.”

The Gate Control theory of pain contends that non-painful inputs can override and reduce painful sensations, “shutting down” the final common pathway for sharp pain to the brain by exciting nerves that transmit cold and vibration senses, just as running a burn under cold water stops the sharp pain. The theory, proposed in 1965 by Ronald Melzack and Patrick Wall, offers a physiological explanation for the previously observed effect of psychology on pain perception.

Related Links:
Bionix


Print article

Channels

Critical Care

view channel
Image: EsoGuard has demonstrated over 90% specificity and 90% sensitivity in identifying Barrett’s Esophagus (Photo courtesy of Lucid Diagnostics)

Biomarker Based Non-Endoscopic Technology Identifies Risk for Esophageal Cancer

Barrett's esophagus (BE) is the benign and treatable precursor condition to esophageal adenocarcinomas (EAC) which is usually diagnosed at an advanced stage and is difficult to treat. Finding BE, a sign... Read more

Surgical Techniques

view channel
Image: Novel surface treatment could prevent deadly hospital infections without antibiotics (Photo courtesy of Penn State)

Novel Surface Treatment Stops Microbes from Adhering to Medical Devices

Hospitals and medical clinics can be the source of nasty infections, resulting in death from infection-related complications and billions in direct medical costs. The biggest culprits, experts say - accounting... Read more

Health IT

view channel
Image: AI can reveal a patient`s heart health (Photo courtesy of Mayo Clinic)

AI Trained for Specific Vocal Biomarkers Could Accurately Predict Coronary Artery Disease

Earlier studies have examined the use of voice analysis for identifying voice markers associated with coronary artery disease (CAD) and heart failure. Other research groups have explored the use of similar... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.